25
total announcements
FISCHER.NS · 15 min delayed
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about Advance Intimation of dispatch of Annual Report 2026 through electronic mode and the Annual General Meeting for 2026 will be conducted through Video Conferencing.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the schedule of their meet with analysts and institutional investors.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026, where the Board of Directors approved and took on record the appointment of Mr. David Yeow as the Additional Independent Director and reconstitution of the Audit Committee.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the outcome of its Board meeting held on 03/09/2026, where it approved the appointment of Mr. David Yeow as the Additional Independent Director and reconstituted the Audit Committee.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced the record date for the purpose of dividend as September 22, 2026, and the register of members and share transfer books will be closed from September 23 to 29, 2026, for the annual general meeting.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Private Ltd., has launched the CLARION 64/128-Slice AI-Driven CT System in India at the India Health Expo 2026.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's step-down subsidiary Time Medical Philippines has been awarded a province-wide digital healthcare project for rollout across Catanduanes Province, deploying an integrated solution combining Health Kiosks with the PhilHealth-accredited FlynnCare Clinic Management System (CMS).
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants. The company has allotted 4,54,210 Equity Shares at an issue price of Rs. 23.40/- (including a premium of Rs. 22.40 per share) upon exercising the option available with the Share Warrant Holder to convert warrants.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants. The company has allotted 2,05,05,909 (Two Crore Five Lakhs Five Thousand and Nine Hundred and Nine Only) Equity Shares at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) upon exercising the option available with the Share Warrant Holder.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced the resignation of two independent directors, Mr. Roberto M Pagdanganan and Mr. Sanjay Jayantilal Jain, due to personal reasons and pre-occupation with other professional commitments.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net loss of ₹350.41 lakhs. The company has also announced the resignation of two independent directors and the reconstitution of the audit and nomination and remuneration committees. Additionally, the company has allotted 2,05,05,909 equity shares to promoters and non-promoters on a preferential basis.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations, detailing the utilization of funds raised through a preferential issue of equity shares and fully convertible share warrants. The report indicates no deviation from the objects of the issue.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the allotment of equity shares pursuant to conversion of warrants. The company has allotted 1,42,78,217 equity shares at an issue price of Rs. 23.40 per share, aggregating to Rs. 25,05,82,708.35.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about allotment of equity shares pursuant to conversion of warrants.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about the allotment of 23,00,000 (Twenty Three Lakhs) Equity Shares upon exercising the option available with the Share Warrant Holder to convert 23,00,000 (Twenty Three Lakhs) Convertible Warrants. The allotment has been made for cash at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) (including a premium of Rs. 22.40 per share) upon the receipt of the remaining exercise price of Rs. 17.55/- per warrant aggregating to Rs. 4,03,65,000/- (Rupees Four Crores Three Lakhs Sixty Five Thousand Only).
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has informed the Exchange about a newspaper advertisement regarding a special window for re-lodgement of transfer requests for physical shares.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited has received regulatory clearance from India's Central Licensing Authority (CDSCO) to import and distribute the Spincare Portable Wound Care System, a first-of-its-kind device in India's wound care market.